A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors

Summary

This phase I trial studies the side effects and best dose of SOR-C13 in treating patients with solid tumors that have spread to other places in the body (advanced) and does not respond to treatment. Drugs used in chemotherapy, such as SOR-C13, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

Timeline

Start

2019-07-29

Primary completion

2023-06-20

Completion

2023-06-20

Drugs

Indications